Oragenics CEO John N. Bonfiglio Acquires 1,000 Shares (OGEN)
Oragenics (NASDAQ:OGEN) CEO John N. Bonfiglio purchased 1,000 shares of Oragenics stock in a transaction that occurred on Wednesday, August 13th. The shares were purchased at an average price of $1.70 per share, for a total transaction of $1,700.00. Following the purchase, the chief executive officer now directly owns 385,255 shares of the company’s stock, valued at approximately $654,934. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Oragenics (NASDAQ:OGEN) traded up 4.79% during mid-day trading on Thursday, hitting $1.75. The stock had a trading volume of 608 shares. Oragenics has a 52-week low of $1.56 and a 52-week high of $4.65. The stock has a 50-day moving average of $1. and a 200-day moving average of $2.48. The company’s market cap is $63.3 million.
Oragenics (NASDAQ:OGEN) last announced its earnings results on Thursday, May 22nd. The company reported ($0.05) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.09) by $0.04. On average, analysts predict that Oragenics will post $-0.37 earnings per share for the current fiscal year.
Oragenics, Inc is focused on the discovery, development and commercialization of a range of technologies associated with oral health, antibiotics and other general health benefits.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.